Roundtable Discussions
The Roundtable Discussions video series highlights hot topics and major developments in clinical practice, patient management, neurology education and neuroscience, and the institutional practices that are setting the standard for the field. Each series includes multiple key opinion leaders who offer their collaborative insight and perspectives, put together collaboratively with various institutional and advocacy partners.
The Beginning of the Biosimilars Era in Multiple Sclerosis
October 19th 2023Jeff Cohen, MD; Alycin Magruder, PharmD; and Sarah Anderson, PharmD, discuss the recent introduction of biosimilars into the therapeutic landscape of multiple sclerosis, and the downstream effects for physicians, patients, and payers in this new era of treatment.
Resources for Providers and Patients
• Generic and Biosimilar Medications | National MS Society
• Generic and Biosimilar FAQs
• 5 Things to Know About Biosimilars - Momentum Magazine
• Ask an MS Expert: Biosimilars and Generics
• Tyruko News Bulletin
• Patient Assistance Program
• Guide to Prescription Financial Assistance
History of SRNA and Advances in Rare Neuroimmune Disorders
September 12th 2023Sanford Siegel, Douglas Kerr, MD; and Benjamin Greenberg, MD, comment on several topics related to the treatment of rare neuroimmune disorders, including complexities with distinguishing certain conditions and where research should be dedicated to in the coming years.
AUPN and the History of Neurology Education
August 28th 2023Robert Griggs, MD; Clifton Gooch, MD; and Henry Kaminski, MD, former presidents of the AUPN, share insight on the changes in neurology and how it is taught, the lessons learned over time, and the future for other neurology department leaders.
